封面
市場調查報告書
商品編碼
2055243

視網膜剝離市場:按疾病、治療方法、產品類型、診斷方法、年齡層、最終用戶和地區分類

Retinal Detachment Market, By Disease Type, By Treatment Type, By Product Type, By Diagnostics, By Age Group, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,視網膜剝離市場價值將達到 30 億美元,到 2033 年將達到 45.1 億美元。預計從 2026 年到 2033 年,該市場將以 6.0% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 30億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.00% 2033年市場規模預測: 45.1億美元

視網膜剝離是一種嚴重的眼科急症,其特徵是神經感覺視網膜與下方的視網膜色素上皮分離,如不及時治療,可導致永久性視力喪失。此疾病的發生機制多種多樣,包括裂孔性脫離、牽拉性脫離和滲出性脫離,每種脫離都需要專門的治療性介入。全球視網膜剝離市場涵蓋了一系列全面的診斷技術、手術器械、藥物和治療設備,旨在應對這種威脅視力的疾病。

光學同調斷層掃描(OCT)、眼底照相和超音波影像成像等先進診斷方法徹底改變了早期檢測能力。同時,氣動視網膜固定術、鞏膜環紮術和玻璃體切除手術等創新手術技術也隨著科技進步而持續發展。此外,微創手術方法、高階人工人工水晶體的引入以及先進玻璃體視網膜手術器械的應用進一步鞏固了市場格局。近視、糖尿病併發症、眼外傷和老齡化相關性退化性改變等風險因素的日益普遍,顯著推動了市場擴張。此外,醫療保健支出的增加、人們對視網膜疾病認知的提高以及獲得專業眼科護理的便利性改善,都推動了該治療領域的顯著成長,視網膜脫離的治療已成為全球綜合眼科醫療保健體系的重要組成部分。

市場動態

全球視網膜剝離市場呈現強勁成長態勢,這主要得益於多項強勁因素的共同推動,這些因素共同提升了市場的擴張前景。關鍵市場促進因素包括全球糖尿病盛行率的快速成長,這顯著增加了糖尿病視網膜病變及其繼發性牽拉性視網膜剝離的風險,從而催生了對先進治療性介入的巨大需求。全球人口老化也是一個重要的成長要素,老齡化相關的退化性改變、後玻璃體脫離以及近視盛行率的上升都會導致視網膜剝離發病率的增加。影像技術的進步,包括高解析度光學同調斷層掃描(OCT)和廣角眼底攝影,使得早期發現和更精準的治療方案製定成為可能,從而改善患者預後並促進市場接受度的提高。

此外,醫療保健支出不斷成長、眼科專科手術保險覆蓋範圍擴大以及預防性眼保健意識的提高,都顯著推動了市場需求。然而,一些限制因素,例如先進玻璃體視網膜手術設備的高成本以及對醫療專業人員的專業培訓要求,正在挑戰市場成長。這些因素可能導致發展中地區醫療服務取得受限。複雜的報銷體系、創新醫療設備漫長的監管核准流程以及可能影響病人接受度的手術併發症,也是限制市場發展的因素。

儘管如此,新興國家醫療基礎設施的擴建、微創手術技術的廣泛應用以及眼科研發投入的增加,正湧現出巨大的機會。人工智慧在診斷影像領域的應用、新藥的研發以及手術器械的進步,都為那些希望利用不斷發展的治療模式的相關人員創造了顯著的成長機會。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數創建了全球視網膜剝離市場主要公司的概況:公司亮點、產品系列、主要特點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球視網膜剝離市場報告旨在為行業內的各種相關人員提供參考,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球視網膜剝離市場時所使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 促進因素
  • 抑制因子
  • 機會
  • 影響分析
  • 主要進展
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景
  • 產業趨勢

第4章 全球視網膜剝離市場:依疾病類型分類,2021-2033年

  • 裂孔性視網膜剝離
  • 牽拉性視網膜剝離
  • 滲出性/漿液性/續發性視網膜剝離

第5章 全球視網膜剝離市場:依治療類型分類,2021-2033年

  • 玻璃體切除手術
  • 鞏膜分區
  • 氣體視網膜固定
  • 雷射治療(例如,光凝固療法)
  • 冷凍療法
  • 其他治療方法(輔助性治療、聯合治療、新治療方法)

第6章 全球視網膜剝離市場:依產品類型分類,2021-2033年

  • 手術器械及設備
  • 耗材和配件(例如,填塞物、氣體、矽油、縫線)

第7章 全球視網膜剝離市場:依診斷方法分類,2021-2033年

  • 數位視網膜相機
  • 眼底照片
  • 眼底內視鏡檢查
  • 螢光視網膜血管造影術
  • 其他診斷方法

第8章 全球視網膜剝離市場:依年齡層別分類,2021-2033年

  • 兒童和青少年
  • 成人
  • 進階的

第9章 全球視網膜剝離市場:依最終用戶分類,2021-2033年

  • 醫院/眼科診所
  • 眼科中心
  • 門診手術中心
  • 其他(例如,診斷檢查室、遠距眼科服務)

第10章 全球視網膜剝離市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第11章 競爭格局

  • Alcon Inc
  • Carl Zeiss Meditec AG
  • Bausch+Lomb Incorporated
  • Topcon Corporation
  • IRIDEX Corporation
  • Ellex Medical Lasers Ltd
  • FCI Ophthalmics
  • Millennium Surgical Corp
  • Leica Microsystems GmbH
  • NIDEK CO., LTD.
  • Escalon Medical Corp
  • Lumenis Ltd
  • Second Sight Medical Products Inc
  • Optos plc
  • Johnson & Johnson Vision

第12章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第13章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI8643

Retinal Detachment Market is estimated to be valued at USD 3 Bn in 2026 and is expected to reach USD 4.51 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 3 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.00% 2033 Value Projection: USD 4.51 Bn

Retinal detachment represents a critical ophthalmological emergency characterized by the separation of the neurosensory retina from the underlying retinal pigment epithelium, potentially leading to permanent vision loss if left untreated. This condition manifests through various mechanisms including rhegmatogenous, tractional, and exudative detachment, each requiring specialized therapeutic interventions. The global retinal detachment market encompasses a comprehensive range of diagnostic technologies, surgical instruments, pharmaceutical agents, and therapeutic devices designed to address this sight-threatening condition.

Advanced diagnostic modalities such as optical coherence tomography, fundus photography, and ultrasound imaging have revolutionized early detection capabilities, while innovative surgical techniques including pneumatic retinopexy, scleral buckling, and vitrectomy procedures continue to evolve with technological advancement. The market landscape is further enhanced by the integration of minimally invasive surgical approaches, premium intraocular lenses, and sophisticated vitreoretinal instrumentation. Rising prevalence of risk factors including myopia, diabetes-related complications, ocular trauma, and age-related degenerative changes significantly contributes to market expansion. Additionally, increasing healthcare expenditure, enhanced awareness regarding retinal disorders, and improved accessibility to specialized ophthalmic care are driving substantial growth in this therapeutic segment, positioning retinal detachment management as a crucial component of comprehensive eye care delivery systems worldwide.

Market Dynamics

The global retinal detachment market demonstrates robust growth trajectories driven by multiple compelling factors that collectively enhance market expansion prospects. Primary market drivers include the escalating prevalence of diabetes mellitus worldwide, which significantly increases the risk of diabetic retinopathy and subsequent tractional retinal detachment, thereby creating substantial demand for advanced therapeutic interventions. The aging global population represents another critical growth driver, as age-related degenerative changes, posterior vitreous detachment, and increased myopia prevalence contribute to heightened retinal detachment incidence rates. Technological advancement in diagnostic imaging, including high-resolution optical coherence tomography and wide-field fundus photography, enables earlier detection and more precise treatment planning, thereby improving patient outcomes and market adoption.

Additionally, increasing healthcare expenditure, enhanced insurance coverage for specialized ophthalmic procedures, and growing awareness regarding preventive eye care significantly boost market demand. However, several restraining factors present challenges to market growth, including the high cost associated with advanced vitreoretinal surgical equipment and specialized training requirements for healthcare professionals, which may limit accessibility in developing regions. Complex reimbursement scenarios, lengthy regulatory approval processes for innovative medical devices, and potential surgical complications that may deter patient acceptance also pose market constraints.

Nevertheless, substantial opportunities emerge through expanding healthcare infrastructure in emerging economies, increasing adoption of minimally invasive surgical techniques, and growing investment in ophthalmic research and development. The integration of artificial intelligence in diagnostic imaging, development of novel pharmacological agents, and advancement in surgical instrumentation present significant growth opportunities for market stakeholders seeking to capitalize on evolving treatment paradigms.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global retinal detachment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Alcon Inc, Carl Zeiss Meditec AG, Bausch + Lomb Incorporated, Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers Ltd, FCI Ophthalmics, Millennium Surgical Corp, Leica Microsystems GmbH, NIDEK CO., LTD., Escalon Medical Corp, Lumenis Ltd, Second Sight Medical Products Inc, Optos plc, and Johnson & Johnson Vision
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global retinal detachment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global retinal detachment market

Market Segmentation

  • Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Rhegmatogenous Retinal Detachment
  • Tractional Retinal Detachment
  • Exudative/Serous/Secondary Retinal Detachment
  • Treatment Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Vitrectomy
  • Scleral Buckling Surgery
  • Pneumatic Retinopexy
  • Laser treatments (e.g. Photocoagulation)
  • Cryopexy
  • Other Treatments (adjuncts, combination therapies, newer modalities)
  • Product Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Surgical Instruments and Equipment
  • Consumables and Accessories (e.g. tamponade agents, gases, silicone oil, sutures)
  • Diagnostics Insights (Revenue, USD Bn, 2021 - 2033)
  • Digital Retinal Camera
  • Fundus Photography
  • Ophthalmoscopy
  • Fluorescent Retinal Angiography
  • Other diagnostic modalities
  • Age Group Insights (Revenue, USD Bn, 2021 - 2033)
  • Children and Adolescents
  • Adults
  • Seniors
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals/Eye Clinics
  • Ophthalmic Centers
  • Ambulatory Surgery Centers
  • Others (e.g. diagnostic labs, remote tele-ophthalmology services)
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Alcon Inc
  • Carl Zeiss Meditec AG
  • Bausch + Lomb Incorporated
  • Topcon Corporation
  • IRIDEX Corporation
  • Ellex Medical Lasers Ltd
  • FCI Ophthalmics
  • Millennium Surgical Corp
  • Leica Microsystems GmbH
  • NIDEK CO., LTD.
  • Escalon Medical Corp
  • Lumenis Ltd
  • Second Sight Medical Products Inc
  • Optos plc
  • Johnson & Johnson Vision

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Retinal Detachment Market, By Disease Type
    • Global Retinal Detachment Market, By Treatment Type
    • Global Retinal Detachment Market, By Product Type
    • Global Retinal Detachment Market, By Diagnostics
    • Global Retinal Detachment Market, By Age Group
    • Global Retinal Detachment Market, By End User
    • Global Retinal Detachment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Retinal Detachment Market, By Disease Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Rhegmatogenous Retinal Detachment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Tractional Retinal Detachment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Exudative/Serous/Secondary Retinal Detachment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Retinal Detachment Market, By Treatment Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Vitrectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Scleral Buckling Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pneumatic Retinopexy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Laser treatments (e.g. Photocoagulation)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Cryopexy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Other Treatments (adjuncts, combination therapies, newer modalities)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Retinal Detachment Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Surgical Instruments and Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Consumables and Accessories (e.g. tamponade agents, gases, silicone oil, sutures)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Retinal Detachment Market, By Diagnostics, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Digital Retinal Camera
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Fundus Photography
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ophthalmoscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Fluorescent Retinal Angiography
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Other diagnostic modalities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Retinal Detachment Market, By Age Group, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Children and Adolescents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Seniors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Retinal Detachment Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals/Eye Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ophthalmic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgery Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (e.g. diagnostic labs, remote tele-ophthalmology services)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Retinal Detachment Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Alcon Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Carl Zeiss Meditec AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bausch + Lomb Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Topcon Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IRIDEX Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ellex Medical Lasers Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FCI Ophthalmics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Millennium Surgical Corp
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Leica Microsystems GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NIDEK CO., LTD.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Escalon Medical Corp
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lumenis Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Second Sight Medical Products Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Optos plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson Vision
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us